Yoichiro Kino

Title: Yoichiro Kino: Innovator in Vaccine Development

Introduction

Yoichiro Kino is a prominent inventor based in Kumamoto, Japan. He has made significant contributions to the field of vaccine development, particularly in the production of conjugate vaccines. With a total of 4 patents to his name, his work has had a substantial impact on immunology and public health.

Latest Patents

Kino's latest patents include innovative methods for producing Hib conjugate vaccines. One notable patent describes a method for producing a Hib conjugate vaccine using polysaccharide (PRP) with lowered molecular weight. This method enhances the storage stability of the vaccine while maintaining its immunogenicity. Another significant patent involves a novel MDCK-derived cell line (B-702) that can be cultured in serum-free conditions. This advancement allows for the large-scale production of viruses for vaccines in a cost-effective and safe manner.

Career Highlights

Throughout his career, Yoichiro Kino has worked with esteemed organizations such as the Chemo-Sero-Therapeutic Research Institute and Km Biologics Co., Ltd. His expertise in vaccine technology has positioned him as a key figure in the development of effective immunization strategies.

Collaborations

Kino has collaborated with notable colleagues, including Keiichi Makizumi and Nobuya Ohtomo. These partnerships have furthered his research and contributed to the advancement of vaccine technologies.

Conclusion

Yoichiro Kino's innovative work in vaccine development has led to significant advancements in public health. His contributions continue to influence the field and pave the way for future innovations in immunology.